How long the liver cancer can live after intervention and targeted medication is not clear yet. The specific survival time should be decided according to the severity of the patient’s condition, the patient’s own situation, the effect of treatment and other factors. It is recommended that patients actively cooperate with doctors for treatment. Liver cancer interventional therapy and targeted drug therapy are generally used for middle and late stage liver cancer patients. The staging of survival can be decided according to the following conditions: 1. Staging of liver cancer: the earlier the staging, the better the prognosis of patients, on the contrary, the worse the prognosis and the shorter the survival time of patients with advanced stage. 2. The patient’s own condition: it can be affected by the patient’s age, health condition, living habits, mentality and other factors. 3. Effectiveness of treatment: Although the methods of treatment are similar, each person’s situation is different, and the effect of treatment will also be different. Interventional therapy and targeted medication can relieve patients’ uncomfortable symptoms, prolong their life cycle and improve their quality of life. However, there is no clear data on the survival cycle of patients after intervention and targeted drug use.